arrow_back Back to App

Easier Access to Pancreatic Islet Transplants by Classifying Them as Organs.

This law changes how pancreatic islet cells used in transplants are regulated, classifying them as organs rather than drugs or biological products. This aims to simplify and speed up access to life-saving transplants for patients, especially those with severe Type 1 diabetes. The new regulatory framework could increase the availability of these procedures.
Key points
Pancreatic islet cells for transplantation will be legally treated as organs, not as drugs or biological products.
This change aims to simplify regulatory processes and potentially increase the availability of transplants for patients.
The Secretary of Health and Human Services must update transplantation regulations within one year.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_4304
Sponsor: Rep. Rosendale Sr., Matthew M. [R-MT-2]
Process start date: 2023-06-22
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

ISLET Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_4304.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-06-22.

What are the main provisions?

Key points include:

  • Pancreatic islet cells for transplantation will be legally treated as organs, not as drugs or biological products.
  • This change aims to simplify regulatory processes and potentially increase the availability of transplants for patients.
  • The Secretary of Health and Human Services must update transplantation regulations within one year.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Rosendale Sr., Matthew M. [R-MT-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

CATEGORIES

Health